Company / CapEx per Share
Candel Therapeutics, Inc. CapEx per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2023
5-year range
$0.02 / $0.13
FY2021-FY2023
Trend
-75.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.13 to $0.02 over the past 2 years.
Based on SEC 10-K filings.
0.02 in FY2023.
Declined from $0.13 to $0.02 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, capex per share decreased 75.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $0.02 | -75.3% |
| FY2022 | $0.06 | -49.6% |
| FY2021 | $0.13 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026